Group 1: Investor Relations Activity - The company held an earnings briefing on May 19, 2025, via online remote access [3] - Participants included the chairman, general manager, board secretary, financial officer, and sponsor representative [3] Group 2: Patent Developments - In 2024, the company added 13 invention patents, 6 utility model patents, and 1 design patent, totaling 33 invention patents, 117 utility model patents, and 5 design patents [4] - New patents cover various fields, including oxygen masks, airborne products, civil aviation functional films, and automotive functional films, enhancing core business competitiveness and market expansion [4] Group 3: Financial Performance - The company reported a loss in 2024, primarily due to a significant decline in sales of oxygen masks, which have a high gross margin [5] - The sales situation for oxygen masks is expected to improve in 2025 based on current orders [5] Group 4: Automotive Film Business - The domestic passenger car production and sales remain stable at around 30 million units in 2024 [6] - The automotive film market is expanding due to increasing consumer demand for comfort and aesthetics, with the company focusing on developing new functional composite films [6] Group 5: Civil Aviation Business - The subsidiary received multiple approvals from the Civil Aviation Administration of China for various products, which are now included in the supplier directories of several airlines [7][8] - The company aims to strengthen cooperation with airlines and achieve significant sales breakthroughs in 2025 [8]
通易航天(871642) - 投资者关系活动记录表